- Home
- INDI vs EBS Comparison
INDI vs EBS Comparison
Compare INDI & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INDI | EBS |
|---|---|---|
| Founded | 2007 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 688.9M | 663.3M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | INDI | EBS |
|---|---|---|
| Price | $4.18 | $11.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $6.25 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 2.7M | 947.6K |
| Earning Date | 02-19-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.35 |
| Revenue | $217,396,000.00 | ★ $788,900,000.00 |
| Revenue This Year | $1.91 | N/A |
| Revenue Next Year | $30.15 | $15.21 |
| P/E Ratio | ★ N/A | $8.14 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.53 | $4.02 |
| 52 Week High | $6.05 | $14.06 |
Technical Indicators
Market Signals| Indicator | INDI | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 55.54 | 40.18 |
| Support Level | $3.78 | $11.54 |
| Resistance Level | $4.47 | $14.06 |
| Average True Range (ATR) | 0.22 | 0.71 |
| MACD | 0.06 | -0.28 |
| Stochastic Oscillator | 69.47 | 14.45 |
Price Performance
Historical ComparisonAbout INDI indie Semiconductor Inc.
Indie Semiconductor Inc is empowering the Autotech revolution with next-generation automotive semiconductors and software platforms. It focuses on edge sensors for Driver Assistance Systems including LiDAR, connected car, user experience, and electrification applications. These technologies represent the core underpinnings of both electric and autonomous vehicles, while the user interfaces transform the in-cabin experience to mirror and seamlessly connect to the mobile platforms. Geographically, the company generates majority of its revenue from Greater China and rest from United States, Europe, South Korea and other regions.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.